Featured
-
Breaking News | Industry News | Promotions & Moves
Cytovance Promotes Jesse McCool to CEO
Yan Wang to step down as Cytovance’s interim chief executive04.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Emergent Signs Manufacturing Agreement with Novavax
Expanded collaboration now includes NanoFlu and COVID-19 vaccine candidateContract Pharma Staff 04.03.20
-
Breaking News | Industry News | Supply Chain
Sai Life Sciences Joins Supply Chain Initiative
Becomes first India-headquartered company to join Pharmaceutical Supply Chain Initiative (PSCI)04.03.20
-
Breaking News | Clinical Trials | Industry News
Pharmaseal Offers No Cost Support for COVID-19 Clinical Trials
Will offer the Engility clinical trials management system at no cost for COVID-19 coronavirus clinical trials04.03.20
-
Breaking News | Clinical Trials | Industry News
Duke to Expedite Study of COVID-19 Prevention in Healthcare Workers
The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine as a preventive drug for the novel coronavirus04.03.20
-
Breaking News | CRO News | Industry News
Frontage Laboratories Acquires Biotranix
Expands drug metabolism and pharmacokinetic services04.03.20
-
Breaking News | Industry News | Promotions & Moves
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trials | Drug Development | Scale-up/Technology Transfer
Rapid Delivery of Medical Countermeasures Amid Pandemic
Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccinesOnline Exclusives Kristin Brooks, Contract Pharma 04.03.20
-
World Class Capsules Now Made in Brazil
ACG's fully operational state-of-the-art facility at Pouso Alegre, Brazil promises faster delivery of quality capsules to the LATAM region
-
Breaking News | Drug Development | Industry News
Ampio Pharma to Study Ampion in COVID-19 Induced ARDS
Englewood pharmaceutical company looking to treat COVID-19 patients with anti-inflammatory drug04.02.20
-
Drug Development | Industry News
Video: Ampio Pharma Studies Ampion in COVID-19 Induced ARDS
Rationale and scientific evidence for the use of Ampion in the treatment of Acute Respiratory Distress Syndrome secondary to SARS-COV-2Videos
-
Breaking News | Collaborations & Alliances | Drug Development
Amgen, Adaptive Biotech Enter COVID-19 Antibody Alliance
Aims to accelerate the development of a potential antibody against COVID-19 as fast as possible04.02.20
-
Breaking News | Clinical Trials | Drug Development | Industry News
APEIRON Biologics Initiates Phase II COVID-19 Trial
APN01 has potential to block infection of cells by COVID-19 virus and reduce lung injury04.02.20
-
Breaking News | Industry News
FDA COVID-19 Update
Develops quality-controlled, reference sequence data for the SARS-CoV-2 reference strain for the U.S.04.02.20
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
COVID-19 Vaccine Response
ICON execs discuss developments in vaccine research efforts and key challenges of delivering a coronavirus vaccineOnline Exclusives Kristin Brooks, Contract Pharma 04.01.20
- Emergent Signs Manufacturing Agreement with Novavax
- Pharmaseal Offers No Cost Support for COVID-19 Clinical Trials
- Duke to Expedite Study of COVID-19 Prevention in Healthcare Workers
- Rapid Delivery of Medical Countermeasures Amid Pandemic
- Ampio Pharma to Study Ampion in COVID-19 Induced ARDS
- Video: Ampio Pharma Studies Ampion in COVID-19 Induced ARDS
- Amgen, Adaptive Biotech Enter COVID-19 Antibody Alliance
- APEIRON Biologics Initiates Phase II COVID-19 Trial
- FDA COVID-19 Update
- COVID-19 Vaccine Response
- Cytovance Promotes Jesse McCool to CEO
- Emergent Signs Manufacturing Agreement with Novavax
- Sai Life Sciences Joins Supply Chain Initiative
- Pharmaseal Offers No Cost Support for COVID-19 Clinical Trials
- Duke to Expedite Study of COVID-19 Prevention in Healthcare Workers
- Frontage Laboratories Acquires Biotranix
- CMAB Bolsters Executive Team
- Cobra Biologics Completes Key CombiGene Milestone
- Ampio Pharma to Study Ampion in COVID-19 Induced ARDS
- Amgen, Adaptive Biotech Enter COVID-19 Antibody Alliance
Contract Service Directory
Search the Directories for A Company:
